Affiliation:
1. Institute for Research in Biomedicine (IRB), Barcelona Science Park, Josep Samitier 1-5, 08028 Barcelona, Spain
2. Department of Organic Chemistry, University of Barcelona, c/Martí i Franquès, 1, 08028 Barcelona, Spain
Abstract
Proline-rich cell-penetrating peptides, particularly the SAP (sweet arrow peptide), (VRLPPP)3, have been proposed to be useful intracellular delivery vectors, as a result of their lack of cytotoxicity combined with their capacity to be internalized by cells. A common limitation of the therapeutic use of peptides is metabolic instability. In general, peptides are quickly degraded by proteases upon entry into the bloodstream. The use of all-D-peptide derivatives is emerging as a fruitful strategy to circumvent this degradation problem. In this context, we report on the internalization behaviour, protease-resistance enhancement and self-assembly properties of an all-D version of SAP [(vrlppp)3]. The cellular uptake of (vrlppp)3 was evaluated in an in vivo assay in mice. Both flow cytometry and confocal laser-scanning microscopy experiments showed that a carboxyfluoresceinated version of the molecule, carboxyfluorescein–(vrlppp)3, is internalized rapidly in white blood cells and kidney cells. Significant fluorescence was also detected in other organs such as the spleen and the liver. Finally, the toxicity of (vrlppp)3 was examined, and no significant differences in the main biochemical parameters nor in weight were detected compared with controls.
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Topoisomeric Membrane-Active Peptides: A Review of the Last Two Decades;Pharmaceutics;2023-10-12
2. Toxicity and Immune Response;CPP, Cell-Penetrating Peptides;2023
3. Introduction;CPP, Cell-Penetrating Peptides;2023
4. Cell-penetrating peptides;De Novo Peptide Design;2023
5. Classification;Cell‐Penetrating Peptides;2022-12-02